Bayer Aktiengesellschaft (BAYZF)
OTCMKTS · Delayed Price · Currency is USD
46.04
+2.16 (4.92%)
At close: Mar 10, 2026
Bayer Aktiengesellschaft Market Cap
Bayer Aktiengesellschaft has a market cap or net worth of $45.33 billion as of March 10, 2026. Its market cap has increased by 94.12% in one year.
Market Cap
45.33B
Enterprise Value
80.08B
Revenue
53.51B
Ranking
n/a
PE Ratio
n/a
Stock Price
$46.04
Market Cap Chart
Since January 1, 1992, Bayer Aktiengesellschaft's market cap has increased from 5.86B to 45.33B, an increase of 673.63%. That is a compound annual growth rate of 6.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 42.81B | 0.10% |
| Dec 30, 2025 | 42.77B | 117.25% |
| Dec 30, 2024 | 19.69B | -46.09% |
| Dec 29, 2023 | 36.52B | -28.02% |
| Dec 30, 2022 | 50.74B | -2.95% |
| Dec 30, 2021 | 52.28B | -10.07% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 791.42M |
| Veradigm | 724.25M |
| Glass House Brands | 718.57M |
| Elite Pharmaceuticals | 429.68M |
| American Oncology Network | 360.64M |
| Northwest Biotherapeutics | 360.57M |
| CytoDyn | 296.04M |
| Silence Therapeutics | 294.27M |